Opens in a new tab

Italian Pasta Manufacturing Business

Italian Pasta Manufacturing Business
Country
ItalyItaly
Listing ID
L#20251027
Target Price
€2,500,000
Revenue
€1,900,000
EBITDA
€850,000

Description

This Italian food producer specializes in creating a healthier take on a global staple: pasta.

The company focuses on manufacturing organic and gluten-free varieties, moving beyond traditional wheat. Their products are innovatively crafted using flours derived from a combination of legumes and cereals, such as chickpeas, lentils, various rice flours, and sometimes incorporating "superfoods" like turmeric or flaxseed.

This approach results in pasta that is not only suitable for those with gluten sensitivities but also boasts significantly higher protein and fiber content, often coupled with a low glycemic index. This makes their offerings an appealing choice for athletes, vegans, vegetarians, and anyone seeking nutritious additions to a balanced diet.

They produce a wide variety of shapes—from fusilli and penne to casarecce and tagliatelle—honoring the rich tradition of Italian cuisine while prioritizing contemporary health and wellness needs. Their mission is rooted in the belief that food can be both delicious and genuinely good for you, achieved through a blend of passion, research, and high-quality, carefully selected raw materials.

Basic Details

Listing ID
L#20251027
Country
Italy
Industry
Manufacturing
Deal Status
Available
Target Price
€2,500,000
Revenue
€1,900,000
EBITDA
€850,000
Revenue Multiple
1.32x
EBITDA Multiple
2.94x

M&A Middle Market Advisory Deal Tombstones 2024

AdvisorDeals
MergersCorp M&A International21
Keith Advisory17
GCG9
JP Morgan41
Jefferies23
Lazard26
Goldman Sachs30

Businesses for Sale

Similar Opportunities

KazakhstanKazakhstanManufacturingL#20261174

Central Asian Chlor-Alkali & Chemicals Manufacturing Platform

The proposed project entails the development of a state-of-the-art, vertically integrated chlor-alkali and downstream specialty chemical manufacturing cluster in Kazakhstan. Capitalizing on abundant domestic salt reserves, competitive operating fundamentals, and strategic Eurasian logistics corridors, the project is structured to substitute…

Target Price
$1,000,000,000
Revenue
$620,000,000
EBITDA
$186,000,000
United StatesUnited StatesManufacturingL#20261103

American Leading Life Sciences Research Services Platform

A leading independent multi-omics service providers in the Americas. The Company provides a comprehensive portfolio of next-generation sequencing (NGS), proteomics, metabolomics, epigenomics, and bioinformatics solutions to research institutions, hospitals, biotechnology companies, and pharmaceutical clients across North and South America. Following…

Target Price
$44,000,000
Revenue
$57,000,000
EBITDA
$3,700,000